Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMC Entertainment Holdings
AMC
|
+$36.2M |
| 2 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$16.5M |
| 3 |
McDonald's
MCD
|
+$14.5M |
| 4 |
Sinclair Inc
SBGI
|
+$12.6M |
| 5 |
IBKC
IBERIABANK Corp
IBKC
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Independence Realty Trust
IRT
|
+$8.78M |
| 2 |
AbbVie
ABBV
|
+$8.19M |
| 3 |
Visa
V
|
+$8.05M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$7.33M |
| 5 |
Keurig Dr Pepper
KDP
|
+$7.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.78% |
| 2 | Technology | 13.29% |
| 3 | Consumer Discretionary | 12.94% |
| 4 | Financials | 10.86% |
| 5 | Communication Services | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Citigroup
C
$222B
| $472K | 0.05% |
7,885
+948
| +14% | +$56.1K |
|
|
NUVA
377
DELISTED
NuVasive, Inc.
NUVA
| $472K | 0.05% |
6,321
-28,866
| -82% | -$2.09M |
|
378
Match Group
MTCH
$9.52B
| $470K | 0.05% |
+28,809
| New | +$493K |
|
379
Host Hotels & Resorts
HST
$15.8B
| $467K | 0.05% |
+25,031
| New | +$457K |
|
380
Progressive
PGR
$130B
| $466K | 0.05% |
11,889
-7,507
| -39% | -$286K |
|
381
Toronto Dominion Bank
TD
$193B
| $465K | 0.05% |
9,278
+2,303
| +33% | +$118K |
|
382
Prestige Consumer Healthcare
PBH
$2.45B
| $459K | 0.05% |
+8,255
| New | +$455K |
|
|
TSE
383
DELISTED
Trinseo
TSE
| $456K | 0.05% |
+6,783
| New | +$455K |
|
|
XHR
384
Xenia Hotels & Resorts
XHR
$1.8B
| $456K | 0.05% |
+26,718
| New | +$479K |
|
|
SHPG
385
DELISTED
Shire pic
SHPG
| $456K | 0.05% |
2,618
+585
| +29% | +$102K |
|
386
PTC Therapeutics
PTCT
$5.87B
| $455K | 0.05% |
+46,232
| New | +$560K |
|
|
JUNO
387
DELISTED
Juno Therapeutics, Inc.
JUNO
| $452K | 0.05% |
+20,376
| New | +$437K |
|
388
ProPetro Holding
PUMP
$1.34B
| $451K | 0.05% |
+35,000
| New | +$473K |
|
389
Teva Pharmaceuticals
TEVA
$43B
| $448K | 0.04% |
+13,953
| New | +$476K |
|
390
Caterpillar
CAT
$373B
| $445K | 0.04% |
+4,801
| New | +$454K |
|
|
DERM
391
DELISTED
Dermira, Inc.
DERM
| $442K | 0.04% |
+12,974
| New | +$419K |
|
|
NLSN
392
DELISTED
Nielsen Holdings plc
NLSN
| $440K | 0.04% |
+10,644
| New | +$456K |
|
393
US Foods
USFD
$23.7B
| $439K | 0.04% |
15,686
+2,293
| +17% | +$62.2K |
|
394
Public Service Enterprise Group
PEG
$36.5B
| $438K | 0.04% |
+9,874
| New | +$436K |
|
395
Marathon Petroleum
MPC
$101B
| $433K | 0.04% |
8,577
-8,261
| -49% | -$411K |
|
|
LM
396
DELISTED
Legg Mason, Inc.
LM
| $428K | 0.04% |
11,841
-15,116
| -56% | -$524K |
|
397
Cigna
CI
$73.3B
| $427K | 0.04% |
+2,913
| New | +$429K |
|
398
Bunge Global
BG
$21B
| $426K | 0.04% |
+5,381
| New | +$403K |
|
399
Bio-Techne
TECH
$11.3B
| $423K | 0.04% |
+16,668
| New | +$430K |
|
400
Ionis Pharmaceuticals
IONS
$10.2B
| $419K | 0.04% |
10,431
-9,569
| -48% | -$430K |
|
Similar funds
Steve Schonfeld's Q1 2017 Portfolio in Review
As of Q1 2017, Steve Schonfeld held 843 positions worth $998M, up 29% from $772M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Steve Schonfeld deployed $186M of net new capital in Q1 2017, opening 316 new positions and adding to 131 existing holdings. Its largest new stake was AMC Entertainment Holdings: 113,380 shares worth $35.7M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was AbbVie, an estimated $8.19M trimmed.
- Steve Schonfeld's largest Q1 2017 buy was AMC Entertainment Holdings: 113,380 shares worth $35.7M.
- Steve Schonfeld added most to Athene Holding Ltd. Class A Common Shares in Q1 2017, an estimated $16.5M increase.
- Steve Schonfeld's biggest Q1 2017 reduction was AbbVie, cutting an estimated $8.19M.
- Steve Schonfeld fully exited Independence Realty Trust in Q1 2017, selling an estimated $8.78M.
- Steve Schonfeld's ten largest holdings make up 15% of its $998M portfolio in Q1 2017.
- Steve Schonfeld opened 316 new positions and closed 270 in Q1 2017.
- Steve Schonfeld's portfolio value rose 29% quarter-over-quarter to $998M.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2017, filed 15 May 2017.